CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ChemoGuide aims to validate a prototype test that predicts effective combination therapies for colorectal cancer patients based on their individual cancer cell responses. The test is designed to improve treatment outcomes and patient prognosis.
The ChemoGuide project will clinically validate a proto-type technology (2treat) developed in the previous “Research for SMEs” project, “Integrated Chemical Synthesis and Cell screening in patient cells (ICSC).
The project will execute a clinical study to evaluate the 2treat test’s capability of predicting which combination therapy that is most efficacious and show no resistance in the individual colorectal cancer patient.
The prediction is based on reading the cell functional output cancer cell…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Mondragon
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Denmark, Hillerod
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Germany, Hamburg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United States, Boulder Co
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
